Skip to main content
. 2020 Aug;8(16):1000. doi: 10.21037/atm-20-5298

Figure 2.

Figure 2

Representative images before and after apatinib treatment in case 1. In this 48-year-old man with primary hepatocellular carcinoma, baseline contrast-enhanced CT (A) demonstrates multifocal tumors. After 8 weeks of therapy with apatinib. Multifocal tumors have decreased in density and size (B), showing greater homogeneity and better defined margins. Findings at follow-up CT represent response according to CT-morphologic criteria.